BioCentury
ARTICLE | Company News

Novo A/S acquires Xellia

May 22, 2013 12:01 AM UTC

Novo A/S (Hellerup, Denmark) will acquire infectious disease company Xellia Pharmaceuticals A/S (Oslo, Norway) from private equity firm 3i Group for about $700 million. In 2008, 3i acquired Xellia, wh...